Tytus Howard

Right Tackle

Age: 30
Free Agency: 2027 (Void)
Accrued Seasons: 7
  • 2026 Salary Cap Charge: $27,911,588 (8.94% of cap)
  • 2026 Cash Payout: $18,000,000 (8.33% of spending)
  • 2026 Cash to Cap Ratio: 0.64
  • Contract Value: $56,000,000 ($18,666,667 APY)
  • Fully Guaranteed Money: $36,002,000
  • Contract Ranking: 8/106 at RT

Current Contract

(Extension, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202327$2,202,000$4,500,000$500,000$2,202,000$7,202,0003.1%
202428$1,125,000$7,075,000$500,000$1,125,000$8,552,9413.3%
202529$1,170,000$9,941,000$500,000$1,170,000$11,581,5884.0%
202630$17,500,000$9,941,000$500,000$0$27,911,5888.9%
2027 📝
February 18: Contract voids
31Void$5,441,000VoidVoid$13,748,0004.2%
202832Void$5,441,000VoidVoid$00.0%
202933Void$2,866,000VoidVoid$0--
Total$21,997,000$45,205,000$2,000,000$4,497,000$68,996,117

Contract Notes

Tytus Howard signed a three year, $56 million extension with the Texans on July 28, 2023. $36 million is fully guaranteed at signing including an $18 million signing bonus. Howard's 2023 and 2024 salaries are fully guaranteed and $1.8 million of his 2025 salary is guaranteed. Howard can earn up to $500,000 in per game bonuses in each season of the contract.

Cash Flows

- fully earned money
- unearned or partially earned money
$18.7M
$37.3M
$56M
2023202420252026
Cash Due$7,500,000$14,500,000$16,000,000$18,000,000
Running Cash$7,500,000$22,000,000$38,000,000$56,000,000
Career Earnings: $63,074,608
Career APY: $9,010,658
Potential Earnings: $81,074,608
Total Guarantees: $48,227,550
Largest Cash Payment: $20,407,882 (2023)
Largest Cap Number: $27,911,588 (2026)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
TexansDraftedExtended20194$12,225,550$3,056,388$12,225,550$12,225,550100.0%$3,056,388
TexansExtensionActive20233$56,000,000$18,666,667$36,002,000$50,849,05890.8%$16,949,686
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Texans7$63,074,608$9,010,658$39,562,0790.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2019Texans$495,000$1,727,827$0$495,000$2,222,8271.1%$7,406,308
2020Texans$1,050,707$1,727,827$0$1,050,707$2,778,5341.3%$1,050,707
2021Texans$1,606,414$1,727,827$0$1,606,414$3,334,2411.7%$1,606,414
2022Texans$2,162,121$1,727,827$0$2,162,121$3,889,9481.8%$2,162,121
2023Texans$2,202,000$4,500,000$500,000$2,202,000$7,202,0003.1%$20,407,882
2024Texans$1,125,000$7,075,000$500,000$1,125,000$8,552,9413.3%$14,470,588
2025Texans$1,170,000$9,941,000$500,000$1,170,000$11,581,5884.0%$15,970,588
2026Texans$17,500,000$9,941,000$500,000$0$27,911,5888.9%$18,000,000
2027Texans$30,000,000$5,441,000$0$0$13,748,0004.2%$0
2028Texans$30,000,000$5,441,000$0$0$00.0%$0
2029Texans$30,000,000$2,866,000$0$0$0--$0
Total$117,311,242$52,116,308$2,000,000$9,811,242$81,221,667$81,074,608

Statistics

YearGames PlayedGames InactiveSnaps
OffenseSpecial
20198845.8%8.4%
202014082.8%12.8%
202115087.0%10.4%
202217094.0%11.0%
20237035.9%4.6%
202416192.0%15.3%
202516188.0%16.8%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$16,433,000$18,666,667
Injury Adjusted$16,433,000$18,666,667
test
OTC Valuation $3.7M $7.5M $11.2M $14.9M $18.7M APY $4.7M $9.4M $14.1M $18.8M $23.4M $11,596,000 $11,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.